5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 8.18▼ | 8.21▼ | 8.24▼ | 8.25▼ | 8.38▼ |
MA10 | 8.20▼ | 8.26▼ | 8.24▼ | 8.32▼ | 7.76▲ |
MA20 | 8.22▼ | 8.25▼ | 8.27▼ | 8.38▼ | 6.92▲ |
MA50 | 8.26▼ | 8.29▼ | 8.32▼ | 7.56▲ | 11.16▼ |
MA100 | 8.25▼ | 8.33▼ | 8.32▼ | 7.05▲ | 18.82▼ |
MA200 | 8.27▼ | 8.33▼ | 8.25▼ | 10.33▼ | 33.10▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.007▼ | -0.008▼ | -0.006▼ | -0.090▼ | 0.566▲ |
RSI | 26.779▼ | 38.347▼ | 40.823▼ | 51.530▲ | 45.781▼ |
STOCH | 3.758▼ | 30.000 | 60.659 | 33.566 | 82.247▲ |
WILL %R | -100.000▼ | -83.333▼ | -81.633▼ | -85.294▼ | -22.283▲ |
CCI | -164.859▼ | -117.014▼ | -101.511▼ | -99.854 | 66.823 |
Thursday, August 28, 2025 09:05 AM
DUBLIN--(BUSINESS WIRE)--Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation ...
|
Thursday, August 28, 2025 06:39 AM
Piper Sandler lowered the firm’s price target on Prothena (PRTA) to $15 from $81 and keeps an Overweight rating on the shares. While the firm was disappointed to see PRX012’s ASCENT program hit ...
|
Thursday, August 28, 2025 06:38 AM
PRX012 showed 27.47 CL amyloid reduction at 400 mg, nearing FDA-defined thresholds. ARIA-E rates reached up to 41.7%, higher than those seen with Leqembi or Lilly drugs. Want to trade this news? Get ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/09/25 | 8.11 | 8.35 | 8.11 | 8.15 | 352,539 |
15/09/25 | 8.18 | 8.35 | 8.10 | 8.16 | 713,691 |
12/09/25 | 8.43 | 8.49 | 8.20 | 8.21 | 551,060 |
11/09/25 | 8.24 | 8.50 | 8.19 | 8.43 | 711,934 |
10/09/25 | 8.34 | 8.47 | 8.20 | 8.305 | 518,651 |
09/09/25 | 8.50 | 8.50 | 8.10 | 8.34 | 916,203 |
08/09/25 | 8.61 | 8.62 | 8.30 | 8.49 | 622,009 |
05/09/25 | 8.24 | 8.585 | 8.21 | 8.55 | 1,128,164 |
04/09/25 | 8.45 | 8.46 | 8.105 | 8.21 | 961,597 |
03/09/25 | 8.24 | 8.47 | 8.16 | 8.39 | 1,210,436 |
|
|
||||
|
|
||||
|
|